Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease
Shudan Wang(McGovern Institute for Brain Research), Bai Lu(GlaxoSmithKline (China))
Cited by 48
Related Papers
BDNF and Activity-Dependent Synaptic Modulation: Figure 1.
|Learning & Memory|2003|938
Interaction between BDNF and Serotonin: Role in Mood Disorders
|Neuropsychopharmacology|2007|783
An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
|Cell Research|2021|135
Presynaptic protein synthesis required for NT-3-induced long-term synaptic modulation
|Molecular Brain|2011|75
Distinct Mechanisms for Neurotrophin-3-Induced Acute and Long-Term Synaptic Potentiation
|Journal of Neuroscience|2005|28